The characterization of PrecisA Monoclonals starts with an extensive literature search to select the most accurate, relevant and clinically significant tissues to use for immunohistochemistry (IHC) characterization. We often present several tissue types in the IHC application data in our product catalog. In addition to positively stained tissue we also display a negative control tissue staining and if relevant clinical cancer tissue staining.
The characterization for Western blot (WB) data follows that same working procedure and starts with a profound literature search to find the best matching lysate. Each PrecisA Monoclonal antibody is supplied with the most relevant characterization data for its specific target.